Recent Posts

News, Investor, Product
Congenica Receives CE Mark for Genomic Analysis Software
Posted 21st July 2021

Congenica Receives CE Mark for Genomic Analysis Software

Read More
Patient Advocacy , genomics , RareDiseases , GLUT1
Discovering Glut1 Deficiency Syndrome
Posted 9th July 2021

Discovering Glut1 Deficiency Syndrome

Read More
News , Blog , genomics
David Atkins welcomes the Government
Posted 7th July 2021

David Atkins welcomes the Government's Life Sciences Sector Vision

Read More
Clinical Cases , RareDiseases , SCYL1 , CalfanSyndrome
Diagnosing CALFAN syndrome after years of uncertainty
Posted 5th July 2021

Diagnosing CALFAN syndrome after years of uncertainty

Read More
Blog , Clinical Cases , genomics , case study , LQT1
Rapid diagnosis of Long QT syndrome protects family from major health risk
Posted 30th June 2021

Rapid diagnosis of Long QT syndrome protects family from major health risk

Read More
News , Investor
Clinical OMICs interview with David Atkins CEO Congenica
Posted 25th June 2021

Clinical OMICs interview with David Atkins CEO Congenica

Read More
Patient Advocacy , RareDiseases , DravetSyndrome , Chapter 1
Raising awareness of Dravet Syndrome
Posted 23rd June 2021

Raising awareness of Dravet Syndrome

Read More
Clinical Cases , events , precision medicine , film , rare diseases
Genomics in the Clinic & the Promise of Precision Medicine
Posted 22nd June 2021

Genomics in the Clinic & the Promise of Precision Medicine

Read More
Blog , Patient Advocacy , RareDiseases , NorrieDisease , Chapter 1
Our story of Norrie Disease
Posted 18th June 2021

Our story of Norrie Disease

Read More
News , Investor
Congenica funded to reduce fatal drug interactions by mapping genes
Posted 17th June 2021

Congenica funded to reduce fatal drug interactions by mapping genes

Read More
Blog
The challenges and opportunities for growth during a global pandemic
Posted 17th June 2021

The challenges and opportunities for growth during a global pandemic

Read More
previous
1 2 3 4 5
... 18 next
News , Investor , Product
Congenica Receives CE Mark for Genomic Analysis Software
Posted 21st July 2021

Congenica Receives CE Mark for Genomic Analysis Software

Read More
Patient Advocacy , genomics , RareDiseases , GLUT1
Discovering Glut1 Deficiency Syndrome
Posted July Jul 9th 2021

Discovering Glut1 Deficiency Syndrome

Read More
News , Blog , genomics
David Atkins welcomes the Government
Posted July Jul 7th 2021

David Atkins welcomes the Government's Life Sciences Sector Vision

Read More
Clinical Cases , RareDiseases , SCYL1 , CalfanSyndrome
Diagnosing CALFAN syndrome after years of uncertainty
Posted July Jul 5th 2021

Diagnosing CALFAN syndrome after years of uncertainty

Read More
Blog , Clinical Cases , genomics , case study , LQT1
Rapid diagnosis of Long QT syndrome protects family from major health risk
Posted June Jun 30th 2021

Rapid diagnosis of Long QT syndrome protects family from major health risk

Read More
News , Investor
Clinical OMICs interview with David Atkins CEO Congenica
Posted June Jun 25th 2021

Clinical OMICs interview with David Atkins CEO Congenica

Read More
Patient Advocacy , RareDiseases , DravetSyndrome , Chapter 1
Raising awareness of Dravet Syndrome
Posted June Jun 23rd 2021

Raising awareness of Dravet Syndrome

Read More
Clinical Cases , events , precision medicine , film , rare diseases
Genomics in the Clinic & the Promise of Precision Medicine
Posted June Jun 22nd 2021

Genomics in the Clinic & the Promise of Precision Medicine

Read More
Blog , Patient Advocacy , RareDiseases , NorrieDisease , Chapter 1
Our story of Norrie Disease
Posted June Jun 18th 2021

Our story of Norrie Disease

Read More
News , Investor
Congenica funded to reduce fatal drug interactions by mapping genes
Posted June Jun 17th 2021

Congenica funded to reduce fatal drug interactions by mapping genes

Read More
Blog
The challenges and opportunities for growth during a global pandemic
Posted June Jun 17th 2021

The challenges and opportunities for growth during a global pandemic

Read More
previous
1 2 3 4 5
... 18 next
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2021 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.